TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06169917

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paced Resonance Frequency Breathing
Description: Participants are required to pace their breathing to their pre-determined individual resonance frequency.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paced Breathing at Natural Frequency
Description: Participants are required to pace their breathing to their pre-determined individual breathing frequency at rest.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heat Stimulations
Description: Participants will undergo a heat stimulation procedure on their left and right foot (the order of which is counterbalanced across participants). During this procedure, there are 10 blocks, with an inter-stimulus interval of 30 seconds between two blocks. During a block, six 6-second heat stimulations (48 degrees) are given. Between the stimulations, the temperature quickly returns to baseline (32 degrees).
Study: NCT04827199

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Artificial Urinary Sphincter implantation
Description: Device preparation (recharge, settings, pairing) Patient preparation Calibration procedure (to verify the device is in full working prior to implantation)~Implantation procedure which includes:~* Perineal approach and bulbar urethral dissection~* Inguinal approach~* Cuff implantation around the urethra~* Transmission cable passing~* Surgery test procedure~* Implantation of the Control Unit~* Closure of the inguinal incision~* Closure of the perineal incision~* Implant disabled mode activation
Study: NCT05294757

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: 1. Hospital exercise cohort: Participants will be consecutively recruited from the scheduled patient list of the falls unit and the outpatient clinics of Hospital 1. After informed consent acquisition, patients will receive a baseline clinical evaluation. Ultrasound measurements and DXA scan will be conducted, and blood samples will be collected, processed, and stored. Patients will be included in the 16-week multicomponent physical exercise program described below. After the completion of the exercise program, at 16-week follow-up, clinical evaluation, ultrasound, DXA, and blood-sample testing will be repeated.
Study: NCT05860036

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-BCMA CAR-T
Description: Autologous BCMA-directed CAR-T cells, infusion intravenously at a target dose of 2.0-4.0 x 10\^6 anti-BCMA CAR+T cells/kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VRd
Description: Bortezomib, Lenalidomide and Dexamethasone
Study: NCT05818449

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DigiNet intervention
Description: Patients with initial diagnosis of NSCLC stage IV in the model region receiving the following interventions:~* broad NGS-based molecular diagnostics and, based thereupon, personalized treatment information within the national Network Genomic Medicine (nNGM) lung cancer~* regular clinical follow-up visits and data documentation in the shared central digital database by participating physicians~* monthly assessment of patient-reported outcomes (PRO) on quality of life, anxiety, and depression~* incorporation of PROs into treatment by physicians~* treatment monitoring and counseling in the case of critical conditions by expert committee
Study: NCT06387043

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance exercises with Virtual Reality Glasses
Description: Balance exercises with Virtual Reality Glasses

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance Exercises with Stroboscopic Glasses
Description: Balance Exercises with Stroboscopic Glasses

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance Exercises with Visual-Based Metaphor Training
Description: Balance Exercises with Visual-Based Metaphor Training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Balance Exercises
Description: Traditional Balance Exercises
Study: NCT05903274

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JSP191
Description: Subjects will receive intravenous JSP191
Study: NCT06568185

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alpha-Lipoic Acid/Vitamin/Mineral Supplement PolyMVA
Description: BIONERV® s the first combination of alpha lipoic acid 300mg and vitamin B complex. Bionerv® is in oral film-coated, orange colour, oblong shape and no marking and embossing on the tablet. Each tablet contains 4 active ingredients as follows: Alpha lipoic acid 300mg, Vitamin B12 (methylcobalamin) 500mcg, Vitamin B6 (pyridoxine) 8mg, Vitamin B1 (thiamine) 39mg. To be taken after meal 1 tablet once daily.
Study: NCT06500039

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Positive Psychological Intervention Program
Description: An intervention method consisting of three good things in life and gratitude activities was determined for the intervention group. It will take four weeks. Three good deeds will be held for two weeks, and gratitude activities will be held for the last two weeks. Participants will record the interventions on a prepared booklet.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Writing Daily Routines
Description: An activity was planned for the control group participants to write their daily routines. They will write down their sleep, nutrition, hygiene and shopping routines, which will be different each week for four weeks. Control group participants will also be given a booklet to write on.
Study: NCT04977817

Intervention type: DIETARY_SUPPLEMENT
Intervention: Similac Probiotic Tri-Blend
Description: Probiotic dietary supplement, Similac Probiotic Tri-Blend
Study: NCT04767542

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Intravenous Infusion
Description: analgesic

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthesia
Description: Local anesthetic agent (Bupivacaine 0.5%) will be injected bilaterally to transverses abdominis muscle
Study: NCT04784845

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: N. lactamica Y92-1009
Description: Lyophilised N. lactamica reconstituted in phosphate-buffered saline
Study: NCT05683340

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 180mg of ETC-1002(bempedoic acid)
Description: 180mg, tablet, once daily, for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo, tablet, once daily, for 12 weeks
Study: NCT05651477

Intervention type: DEVICE
Intervention: Wearable Device (Smart Watch)
Description: A smart watch refers to an embedded system portable watch equipped with improved functions than a general watch, and is almost always in the form of a wrist watch. The device we are using is the Samsung Galaxy 4 (SM-R860/870).

Intervention type: DEVICE
Intervention: Wearable Device (Smart Watch)
Description: A smart watch refers to an embedded system portable watch equipped with improved functions than a general watch, and is almost always in the form of a wrist watch. The device we are using is the Samsung Galaxy 4 (SM-R860/870).

Intervention type: DEVICE
Intervention: Edge-Box
Description: Edge-Box collects data such as air. The device we are using is the TDS Mfepc-4C2R.
Study: NCT05818163

Intervention type: DEVICE
Intervention: electroencephalography spectral analysis
Description: Before inducing general anesthesia in the patient entering the operating room, an anesthesia depth monitoring patch is attached to the forehead, and EEG data during anesthesia is collected using the currently used anesthesia depth monitoring device.~The EEG data is transformed into a frequency and energy distribution and density spectral array (DSA) graph using Fourier transform (FFT) for spectral analysis.

Intervention type: DEVICE
Intervention: electroencephalography spectral analysis
Description: Before inducing general anesthesia in the patient entering the operating room, an anesthesia depth monitoring patch is attached to the forehead, and EEG data during anesthesia is collected using the currently used anesthesia depth monitoring device.~The EEG data is transformed into a frequency and energy distribution and density spectral array (DSA) graph using Fourier transform (FFT) for spectral analysis.
Study: NCT05238298

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive Transcranial Magnetic Stimulation
Description: A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the cerebral cortex.
Study: NCT05651477

Intervention type: DEVICE
Intervention: Edge-Box
Description: Edge-Box collects data such as air. The device we are using is the TDS Mfepc-4C2R.
Study: NCT05084209

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parkinson's medical decision making support
Description: Participants will be asked to view and work through medical decision making support resources. The resources will include information on medical decisions that may occur in Parkinson's disease, and general medical decisions that anyone may need to make (i.e. choosing a medical decision maker). The resources will also include suggestions on how to discuss these decisions.
Study: NCT05626829

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranilast
Description: Tranilast capsules 100mg 3 times per day when reradiation
Study: NCT06536816

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Game Profile-based training Group
Description: Game profile-based training is a methodology in sports, including football, where training sessions are designed to simulate the specific conditions and challenges that players face during actual games. Coaches analyze individual and team performance data to identify patterns, positions, and scenarios commonly encountered in matches. The training is then structured to replicate these situations, helping players develop the skills, tactics, and decision-making abilities required in real-game scenarios. This approach aims to make training more targeted and relevant to the dynamics of competitive play.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Small-sided games Group
Description: small-sided game in football, often referred to as a SSG, is a practice or training activity where players compete in a reduced playing area with fewer players than a full team.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined training Group with both Game Profile-based training and Small-sided Games
Description: Combined training Group with both Game Profile-based training and Small-sided Games
Study: NCT06201910

Intervention type: OTHER
Intervention: Observation of Blood loss
Description: Retrospetive observation of bloodloss and RBC transfusions.

Intervention type: OTHER
Intervention: Observation of Blood loss
Description: Retrospetive observation of bloodloss and RBC transfusions.

Intervention type: OTHER
Intervention: Observation of Blood loss
Description: Retrospetive observation of bloodloss and RBC transfusions.
Study: NCT06386471

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole grain rye bread
Description: Single consumption of 4.3 oz of whole grain rye bread

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Refined grain rye bread
Description: Single consumption of 4.3 oz of refined grain rye bread
Study: NCT04475744

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF treatment for Bone marrow derived stem cell Mobilization
Description: Mobilization treatment. On the fifth day, collection will be started.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma ovarian injection
Description: Mobilized peripheral blood will be obtained to prepare the PRP for injection. Both ovaries will be injected when proper anatomical access can be assessed.
Study: NCT04771169

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: vestibular Training Group
Description: this Group will receive vestibular Adaptation \& Balance exercises

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Group
Description: This Group will receive Virtual Reality Training by using exergaming.
Study: NCT05610553

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D printing guide plate
Description: 3D-printed customized guide plate will be used to guide the puncture in percutaneous disc decompression surgeries to help to reduce intra-operative radiation, puncture time, etc..

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional guidance
Description: The surgeons would place the needle according to his/her previous experience under the guidance of C-arm fluoroscopy or CT.
Study: NCT05450432

Intervention type: DRUG
Group type: OTHER
Intervention: Ketamine
Description: Study participants will start treatment including two ketamine infusion visits per week during the acute phase, for up to eight ketamine infusion visits. Participants will then be transitioned to maintenance with intranasal esketamine.

Intervention type: DRUG
Group type: OTHER
Intervention: Esketamine
Description: After one month from the eighth ketamine infusion visit, participants will initiate weekly esketamine for 12 weeks, for a total of 13 esketamine treatments. The esketamine visits will happen as per standard of care at the clinic and as instructed by the SPRAVATO Risk Evaluation and Mitigation Strategy.
Study: NCT05034692

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total laparoscopic with intracorporeal anastomosis by overlap method
Description: After the intestinal canal was dissociated and vascularized, the intestinal canal was nuded and cut off, and the distal and proximal intestinal canals were overlapped by 6 cm

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic-assisted colectomy with extracorporeal anastomosis
Description: After the corresponding colon and blood vessels were dissociated and treated, the carbon dioxide pneumoperitoneum was removed. The appropriate length of the incision was cut at the corresponding position of the abdomen, and the incision protector was placed. The tumor was lifted together with the free intestinal canal to the outside of the abdomen. The intestinal canals at the quasi-dismembered sites on both sides of the tumor were nuded, and the colon-colon functional end-to-end anastomosis was performed.
Study: NCT04937569

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Tablets
Description: 4-days course of Ivermectin 400 microgram/kg body weight maximum 4 tablets (6mg / tablet) once daily dose before breakfast

Intervention type: DRUG
Group type: OTHER
Intervention: Ivermectin Tablets
Description: 4-days course of Ivermectin 400 microgram/kg body weight maximum 4 tablets (6mg / tablet) once daily dose before breakfast
Study: NCT05369234

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 100% Aloe Vera Juice
Description: George's 100% Aloe Vera Liquid Supplement

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 100% Aloe Vera Juice
Description: George's 100% Aloe Vera Liquid Supplement

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Magic Mouthwash
Description: Magic Mouthwash

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Magic Mouthwash
Description: Magic Mouthwash

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Magic Mouthwash
Description: Magic Mouthwash

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Magic Mouthwash
Description: Magic Mouthwash

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Salt and Baking soda rinse
Description: Mouth rinse made with salt and baking soda

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Salt and Baking soda rinse
Description: Mouth rinse made with salt and baking soda

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Salt and Baking soda rinse
Description: Mouth rinse made with salt and baking soda

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Salt and Baking soda rinse
Description: Mouth rinse made with salt and baking soda

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carafate
Description: Carafate taken as a slurry

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carafate
Description: Carafate taken as a slurry

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carafate
Description: Carafate taken as a slurry
Study: NCT06307678

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Hydroxide
Description: The samples were taken from the interstitial fluid of the apical tissues using 3 paper points before medicament placement.~Calcium hydroxide based medicament was placed in the canals using a file at a distance of 1 or 2 mm less than the root canal length.~At the second appointment, medicamentswere removed, and second samplingwas performed using the same method.~The RANKL/OPG, TNF alpha, TGF beta, PGE2 levels were measured by the enzyme-linked immunosorbent assay, and their ratio was calculated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium Silicate
Description: The samples were taken from the interstitial fluid of the apical tissues using 3 paper points before medicament placement.~Calcium silicate based medicament was placed in the canals using a file at a distance of 1 or 2 mm less than the root canal length. At the second appointment, medicaments were removed, and second sampling was performed using the same method.~The RANKL/OPG, TNF alpha, TGF beta, PGE2 levels were measured by the enzyme-linked immunosorbent assay, and their ratio was calculated.
Study: NCT05369234

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carafate
Description: Carafate taken as a slurry
Study: NCT05001399

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Holographic Memory Resolution® (HMR)
Description: Clients will participate in Holographic Memory Resolution® (HMR) administered by a trained HMR practitioner. Clients will be introduced to relaxation techniques and safe scene identification. This exercise encourages the client to identify a place in which they feel safe and where nobody can be there without client's invitation. Clients will then describe the place and associated colors of the experience, how the colors move in their body, and how they move through their safe scene. The subsequent 2-3 sessions will continue to explore safe scene and color therapy.
Study: NCT04099082

Intervention type: OTHER
Intervention: samples
Description: blood sample nasal swab

Intervention type: OTHER
Intervention: samples
Description: blood sample nasal swab
Study: NCT05248269

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation
Description: The 2 pertinent contacts connect to Radiofrequency thermocoagulation lesion-generator equipment (Cosman G4 with Ad-tech electrodes), expressly modified for use with SEEG electrodes. The following parameters will be adopted: current power 3 W within 180 seconds and current intensity (usually approximately 25 mA) variable according to impedance.
Study: NCT05777070

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bimanual Cup Stacking Training
Description: Children practices bimanual cup stacking, 15 trials/day for 5 consecutive days

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Bimanual Cup Stacking Training
Description: Children practices bimanual cup stacking, 15 trials/day for 5 consecutive days
Study: NCT00935896

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low tidal volume
Description: twenty patients were randomly (opaque sealed envelopes) assigned to receive mechanical ventilation in volume-controlled mode either with VT of 10-12 ml/kg predicted body weight (high VT group, n=10) or with VT of 5-7 ml/kg predicted body weight (low VT group, n=10) with an inspiratory fraction of oxygen (FIO2) set at the minimal level at which an arterial oxygen saturation of \> 90% and minimal PEEP (4-5cmH2O). The predicted body weight of male patients was calculated as equal to 50+0.91(centimeters of height-152.4); that of female patients was calculated as equal to 45.5+0.91(centimeters of height-152.4).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low tidal volume
Description: Immediately after ICU admission, once all inclusion and exclusion criteria were met and consent obtained, twenty patients (16 men, 4 women, median age of 49 yrs) were randomly (opaque sealed envelopes) assigned to receive mechanical ventilation in volume-controlled mode either with VT of 10-12 ml/kg predicted body weight (high VT group, n=10) or with VT of 5-7 ml/kg predicted body weight (low VT group, n=10) with an inspiratory fraction of oxygen (FIO2) set at the minimal level at which an arterial oxygen saturation of \> 90% and minimal PEEP (4-5cmH2O). The predicted body weight of male patients was calculated as equal to 50+0.91(centimeters of height-152.4); that of female patients was calculated as equal to 45.5+0.91(centimeters of height-152.4)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low tidal volume
Description: tidal volume of 5-7 ml/kg predicted body weight
Study: NCT05124808

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive glycemic targets
Description: Fasting blood glucose \<90 mg/dL, 1 hour post-prandial blood glucose \<120 mg/dL

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard glycemic targets
Description: Fasting blood glucose \<95 mg/dL, 1 hour post-prandial blood glucose \<140 mg/dL
Study: NCT06189196

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BLOW BOTTLE
Description: Blow Bottle PEP' is the cost-effective device comparative to other PEP devices. Treatment (CPT) along with BBPEP twice a day. Therapist made a cost-effective BBPEP which generates 10 cm of H2O PEP and it was given for 10 breaths, 3 sets with 5 second hold.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACBT
Description: Active cycle of breathing technique (ACBT) is an alternative airway clearance technique. A typical ACBT cycle consists of breathing control, three to four thoracic expansion exercises, and a forced expiratory technique (huffing). ACBT has been shown to improve short-term secretion clearance in patients with chronic lung disease. It is also flexible, tolerated, and accepted well by patients. Although ACBT is widely used in patients with respiratory conditions characterized by chronic sputum production.
Study: NCT05285696

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSB-111
Description: \[68Ga\]-NOTA-hGZP is a PET imaging agent.